| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/19/2009 | US20090074814 DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40 |
| 03/19/2009 | US20090074813 Compositions And Methods Using Variant Tat Proteins |
| 03/19/2009 | US20090074812 Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
| 03/19/2009 | US20090074811 Kennel cough vaccine |
| 03/19/2009 | US20090074810 Modified Adenovirus Hexon Protein and Uses Thereof |
| 03/19/2009 | US20090074808 Secreted Streptococcus Pneumoniae Proteins |
| 03/19/2009 | US20090074807 Moraxella (branhamella) catarrhalis antigens |
| 03/19/2009 | US20090074806 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 03/19/2009 | US20090074805 Yeast-based Therapeutic for Chronic Hepatitis C Infection |
| 03/19/2009 | US20090074804 Vero cell-based influenza virus strains and vaccines |
| 03/19/2009 | US20090074803 Immunogen platform |
| 03/19/2009 | US20090074802 Immunomodulating oligopeptides |
| 03/19/2009 | US20090074801 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p 7 |
| 03/19/2009 | US20090074800 Cancer antigen and use thereof |
| 03/19/2009 | US20090074799 Antibodies to class ii cytokine receptor-7 |
| 03/19/2009 | US20090074798 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 03/19/2009 | US20090074797 useful in the management of various cancers which express 20P2H8, particularly including cancers of the bladder, prostate, colon and pancreas |
| 03/19/2009 | US20090074796 Pde5 inhibitor compositions and methods for immunotherapy |
| 03/19/2009 | US20090074795 Methods for addressing ocular diseases through interference with the wnt signaling pathway |
| 03/19/2009 | US20090074794 for use in the treatment of crohn's and ulcerative colitis; administering a composition comprising an effective amount of at least one isolated mammalian anti-tumor necrosis factor (TNF) antibody comprising at least one variable region comprising SEQ ID NO:7 and 8 |
| 03/19/2009 | US20090074793 High Affinity Human Antibodies to Human IL-4 Receptor |
| 03/19/2009 | US20090074792 Compositions containing full-length L1R nucleic acid and endoplasmic reticulum-targeting sequence, and methods of use |
| 03/19/2009 | US20090074791 Phenylisoquinoline and Phenylquinazoline Derivatives |
| 03/19/2009 | US20090074790 Methods for measuring transforming growth factor beta (TGF-beta) receptor signaling activity and uses thereof |
| 03/19/2009 | US20090074789 Compositions and methods for treating ocular diseases and conditions |
| 03/19/2009 | US20090074788 Antibody Against Periostin, and a Pharmaceutical Composition comprising it for Preventing or Treating a Disease in which Periostin is Involved |
| 03/19/2009 | US20090074787 Anti-CTLA4 Antibody and Indolinone Combination Therapy for Treatment of Cancer |
| 03/19/2009 | US20090074786 Formulations for treating ocular diseases and conditions |
| 03/19/2009 | US20090074785 Compositions and methods for treatment of colorectal cancer |
| 03/19/2009 | US20090074784 Treatment of chronic viral diseases with antibodies to costimulating polypeptide of T cells |
| 03/19/2009 | US20090074783 isolated and purified protein produced by a naturally occurring Babesia sp. and an isolated and purified nucleic acid encoding the above protein; use in diagnosing and treating a mammal infected with a Babesia sp. |
| 03/19/2009 | US20090074782 Compositions and Methods for Treating and Diagnosing Cancer |
| 03/19/2009 | US20090074781 Dengue virus peptide vaccine and methods of preparing and using the same |
| 03/19/2009 | US20090074780 Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 03/19/2009 | US20090074779 Neurotrophin-derived peptide sequences |
| 03/19/2009 | US20090074778 human monoclonal or polyclonal antibodies or fragments, that specifically binds to proteins in a blot analysis or enzyme-linked immunosorbent assay; detection of proteins in biological samples |
| 03/19/2009 | US20090074777 Wnt proteins and detection and treatment of cancer |
| 03/19/2009 | US20090074776 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence |
| 03/19/2009 | US20090074775 Use Of Anti-AB Antibody To Treat Traumatic Brain Injury |
| 03/19/2009 | US20090074774 Fgfr binding peptides |
| 03/19/2009 | US20090074773 Cancer vaccine |
| 03/19/2009 | US20090074772 Anti-CD70 Antibody and Its Use for the Treatment of Cancer and Immune Disorders |
| 03/19/2009 | US20090074771 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 03/19/2009 | US20090074770 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof |
| 03/19/2009 | US20090074769 Glp-1 analog fusion proteins |
| 03/19/2009 | US20090074768 Activin-actriia antagonists and uses for treating or preventing breast cancer |
| 03/19/2009 | US20090074766 Methods of inhibiting HIV-2 infection |
| 03/19/2009 | US20090074765 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 03/19/2009 | US20090074764 Methods for diagnosing and treating neuroendocrine cancer |
| 03/19/2009 | US20090074763 Method for inhibiting bone resorption |
| 03/19/2009 | US20090074762 Therapeutic use of anti-tweak receptor antibodies |
| 03/19/2009 | US20090074761 Therapeutic beta-glucan combinations |
| 03/19/2009 | US20090074760 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant |
| 03/19/2009 | US20090074759 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents; administering an antibody or antigen binding fragment thereof that specifically binds to upregulated OX-2/CD200 |
| 03/19/2009 | US20090074758 IL-17 receptor a antigen binding proteins |
| 03/19/2009 | US20090074757 Antitumor Combination Comprising Substituted Acryloyl Distamycin Derivatives and Antibodies Inhibiting Growth Factors or Their Receptors |
| 03/19/2009 | US20090074756 Use of llt1 and/or cd161 for modulatting the activity of cells of the immune system |
| 03/19/2009 | US20090074755 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| 03/19/2009 | US20090074754 Methods and compositions useful in the treatment of mucositis |
| 03/19/2009 | US20090074753 Platelet-derived growth factor compositions and methods of use thereof |
| 03/19/2009 | US20090074752 Surrogate Therapeutic Endpoint For Anti-CTLA-4 Based Immunotherapy Of Disease |
| 03/19/2009 | US20090074751 Growth factor fraction compositions and methods |
| 03/19/2009 | US20090074750 Regulator of basal cellular calcium concentration and methods of use |
| 03/19/2009 | US20090074749 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs |
| 03/19/2009 | US20090074748 Immunological control of beta-amyloid levels in vivo |
| 03/19/2009 | US20090074747 Methods and Compositions for Treating Allergic Diseases |
| 03/19/2009 | US20090074746 Compounds to treat alzheimer's disease |
| 03/19/2009 | US20090074745 Treatment and prevention of tissue damage |
| 03/19/2009 | US20090074741 Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response |
| 03/19/2009 | US20090074726 Mva expressing modified hiv envelope, gag, and pol genes |
| 03/19/2009 | US20090074720 Methods for decreasing immune response and treating immune conditions |
| 03/19/2009 | US20090074719 Peptides, Peptidomimetics and Small Molecule Inhibitors of the Epstein-Barr Virus Mediated Fusion and Entry Process |
| 03/19/2009 | US20090074718 Avian derived erythropoietin |
| 03/19/2009 | US20090074714 Method for Treating Urinary Bladder Cancer |
| 03/19/2009 | US20090074712 Methods for Treatment and Prevention of Infection |
| 03/19/2009 | US20090074711 Human therapies using chimeric agonistic anti-human cd40 antibody |
| 03/19/2009 | US20090074666 Peptide vaccine for influenza virus |
| 03/19/2009 | US20090074662 Cancerous Disease modifying antibodies |
| 03/19/2009 | US20090074661 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 03/19/2009 | US20090074660 Human Monoclonal Antibodies To O8E |
| 03/19/2009 | US20090074659 Cancerous disease modifying antibodies |
| 03/19/2009 | US20090074657 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof |
| 03/19/2009 | DE102007044673A1 Impfstoff zur Behandlung von Zöliakie und Verfahren zur Herstellung des Impfstoffes, Verwendung einer mit einem bakteriellen Toxin konjugierten Peptidsequenz zur Aktivierung des Immunsystems gegen Prolamine sowie Designerpeptid Vaccine for the treatment of celiac disease and method of producing the vaccine, Use of a conjugated with a bacterial toxin peptide sequence for activating the immune system against prolamines and Designer peptide |
| 03/19/2009 | CA2737126A1 Novel p2x7 epitopes |
| 03/19/2009 | CA2699513A1 Gas57 mutant antigens and gas57 antibodies |
| 03/19/2009 | CA2699465A1 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 03/19/2009 | CA2699410A1 Attenuated mycoplasma gallisepticum strains |
| 03/19/2009 | CA2699367A1 Live attenuated mycoplasma strains |
| 03/19/2009 | CA2699366A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/19/2009 | CA2699225A1 Streptococcus pneumoniae vaccines |
| 03/19/2009 | CA2699120A1 Apparatus and method for dehydrating biological materials |
| 03/19/2009 | CA2699093A1 Malva mosaic virus and virus-like particles and uses thereof |
| 03/19/2009 | CA2698990A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | CA2698821A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698809A1 Homogeneous antibody populations |
| 03/19/2009 | CA2698382A1 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 03/19/2009 | CA2698157A1 Novel polysaccharide immunogens from clostridium difficile |
| 03/19/2009 | CA2696963A1 Compositions and methods for preventing influenza infection in canines, felines and equines |
| 03/19/2009 | CA2693852A1 Humanized anti-fgf19 antagonists and methods using same |
| 03/19/2009 | CA2693310A1 Lox and loxl2 inhibitors antibodies and uses thereof |